Integrasi Senyawa Alam Dan Teknologi Komputasi Dalam Pengembangan Obat Modern: Tinjauan Kimia Medisinal
DOI:
https://doi.org/10.31004/joecy.v6i2.10421Keywords:
medicinal chemistry, natural compounds, molecular docking, QSAR,, drug designAbstract
The rapid evolution of modern medicinal chemistry has increasingly transcended traditional trial-and-error methodologies, embracing a more integrative paradigm that combines the exploration of bioactive natural compounds with advanced computational technologies. This study aims to critically examine the significance of such integration in contemporary drug development by analyzing 15 scientific publications, comprising 10 peer-reviewed international journals and 5 scholarly works by Saeful Amin. Employing a descriptive-qualitative literature review approach, this research synthesizes current findings to identify emerging trends, methodological advancements, and their implications for pharmaceutical innovation.
The results reveal that natural compounds including flavonoids, alkaloids, and terpenoids exhibit remarkable potential as lead compounds due to their extensive structural diversity, evolutionary optimization, and broad-spectrum biological activities. Concurrently, computational techniques such as molecular docking, quantitative structure–activity relationship (QSAR) modeling, and artificial intelligence (AI)-driven drug design significantly enhance the efficiency, precision, and predictive capacity of drug discovery processes. Moreover, the synergistic integration of in silico simulations with in vitro experimental validation is shown to be pivotal in accelerating lead identification, optimizing pharmacokinetic properties, and reducing the risk of late-stage drug failure.
In conclusion, the convergence of natural product research and computational methodologies represents a transformative strategy in modern medicinal chemistry, enabling the development of more effective, targeted, and sustainable therapeutic agents while addressing the growing complexity and cost of pharmaceutical research.
References
Amin, S., & Wulandari, R. (2025). Tinjauan kimia medisinal dalam pengembangan obat berbasis flavonoid: Studi literatur. Jurnal Ilmiah Kedokteran dan Kesehatan, 5(1), 45–58. https://doi.org/10.55606/klinik.v5i1.5538
Amin, S., & Yuslahul, U. (2025). Pengaruh struktur molekuler terhadap aktivitas biologis senyawa bioaktif dalam kajian kimia medisinal. Journal of Pharmaceutical and Sciences, 8(2), 120–131. https://doi.org/10.36490/journal-jps.com.v8i2.18832
Amin, S., & Yuslahul, U. (2025). Pengaruh struktur molekuler terhadap aktivitas biologis senyawa bioaktif dalam kajian kimia medisinal. Journal of Pharmaceutical and Sciences, 8(2), 120–131. https://doi.org/10.36490/journal-jps.com.v8i2.18832
Amin, S., Cahyani, R. P., & Riyanti, A. (2026). Systematic study of multitarget molecular docking: From polypharmacology to tissue pharmacology. Jurnal Ilmu Medis Indonesia, 5(2), 21–33. https://doi.org/10.35912/jimi.v5i2.5697
Amin, S., Hidayat, M., & Kurniawan, A. (2025). Molecular studies as a key strategy in medicinal chemistry for drug optimization. Journal of Pharmaceutical and Sciences, 8(1), 15–27. https://doi.org/10.36490/journal-jps.com.v8i1.18811
Amin, S., Pratama, R., & Lestari, D. (2025). In silico study of flavonoid compounds as antidiabetic agents through molecular docking approach. Journal of Pharmaceutical and Health Sciences, 4(2), 67–79. https://doi.org/10.56127/jophs.v4i2.2215
Amin, S., Ramdani, T. A., Salsabila, M. G., & Zulmi, T. N. (2025). Molecular docking analysis of bioactive compounds for cardiovascular disease therapy. Jurnal Riset Rumpun Ilmu Kesehatan, 4(1), 44–57. https://doi.org/10.55606/jurrikes.v4i1.4504
Amin, S., Utami, F., & Maulidya, S. (2021). Virtual screening of flavonoid compounds as a main protease inhibitor for anti-SARS-CoV-2 candidates. Indonesian Journal of Pharmaceutical Science and Technology, 8(3), 101–110. https://doi.org/10.24198/ijpst.v8i3.33682
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., Consonni, V., Kuz’min, V. E., Cramer, R., Benigni, R., Yang, C., Rathman, J., Terfloth, L., Gasteiger, J., Richard, A., & Tropsha, A. (2014). QSAR modeling: Where have you been? Where are you going to? Journal of Medicinal Chemistry, 57(12), 4977–5010. https://doi.org/10.1021/jm4004285
Danova, A., Wonganan, P., Hermawati, E., Kurniadewi, F., Musthapa, I., & Chavasiri, W. (2023). Experimental and molecular docking study of chalcone derivatives. Jurnal Kimia Valensi, 11(2), 145–156. https://doi.org/10.15408/jkv.v11i2.46483
Danova, A., Wonganan, P., Hermawati, E., Kurniadewi, F., Musthapa, I., & Chavasiri, W. (2023). Experimental and molecular docking study of chalcone derivatives. Jurnal Kimia Valensi, 11(2), 145–156. https://doi.org/10.15408/jkv.v11i2.46483
Dolatkhah, Z., Javanshir, S., & Sadr, A. S. (2017). Molecular docking and biological evaluation of chromone derivatives. Journal of Chemical Information and Modeling, 57(6), 1246–1257. https://doi.org/10.1021/acs.jcim.6b00138
H. L. (2016). Molecular docking studies of novel compounds. RSC Advances, 6, 30412–30424. https://doi.org/10.1039/C5RA28141E
Lionta, E., Spyrou, G., Vassilatis, D. K., & Cournia, Z. (2014). Structure-based virtual screening for drug discovery: Principles and applications. Current Topics in Medicinal Chemistry, 14(16), 1923–1938. https://doi.org/10.2174/1568026614666140929124445
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26. https://doi.org/10.1016/S0169- 409X(00)00129-0
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0
Mehta, S., Kumar, S., Marwaha, R. K., Narasimhan, B., Ramasamy, K., Lim, S. M., Shah, S. A. A., & Mani, V. (2019). Synthesis, molecular docking and biological potentials of novel compounds. BMC Chemistry, 13(113), 1–15. https://doi.org/10.1186/s13065-019-0629-0
Meng, X. Y., Zhang, H. X., Mezei, M., & Cui, M. (2011). Molecular docking: A powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146–157. https://doi.org/10.2174/157340911795677602
Newman, D. J., & Cragg, G. M. (2020). Natural products as sources of new drugs over nearly four decades. Journal of Natural Products, 83(3), 770–803. https://doi.org/10.1021/acs.jnatprod.9b01285
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., & Zhao, S. (2019). Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery, 18(6), 463–477. https://doi.org/10.1038/s41573-019-0024-5
Yang, M. R., Qin, Y. J., Chen, C., Zhang, Y. L., Li, B. Y., Liu, T. B., Gong, H. B., Wang, B. Z., & Zhu,
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Saeful Amin, Shahila Nor Chahyani, Ira Akhira Ariyanti, Muhammad alliful ma'aruf

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.







